Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wester

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Nature Communications|November 23, 2016
Atomically resolved phase transition of fullerene cations solvated in helium dropletsM Kuhn, M Renzler, J Postler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 11, 2026
In vitro reversible enzyme inhibition assays to predict drug-drug interactions: Current state and industry perspective from the IQ Consortium Enzyme Inhibition Working GroupCarlo Sensenhauser, Sarah M Glass, Upendra P Dahal, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|October 4, 2006
Effects of molecular rotation in low-energy electron collisions of H3+Andreas Wolf, H Kreckel, L Lammich, et al.
Physical Review Letters|February 21, 2006
High-resolution dissociative recombination of cold H3+and first evidence for nuclear spin effectsH Kreckel, M Motsch, J Mikosch, et al.
ESMO Open|April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoringB Gyawali, E G E de Vries, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2025
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)N I Cherny, S F Oosting, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2023
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0B Kiesewetter, U Dafni, E G E de Vries, et al.
British Journal of Haematology|November 3, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myelomaM R Seefat, D G J Cucchi, L van Boven, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Nature Communications|November 23, 2016
Atomically resolved phase transition of fullerene cations solvated in helium dropletsM Kuhn, M Renzler, J Postler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 11, 2026
In vitro reversible enzyme inhibition assays to predict drug-drug interactions: Current state and industry perspective from the IQ Consortium Enzyme Inhibition Working GroupCarlo Sensenhauser, Sarah M Glass, Upendra P Dahal, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|October 4, 2006
Effects of molecular rotation in low-energy electron collisions of H3+Andreas Wolf, H Kreckel, L Lammich, et al.
Physical Review Letters|February 21, 2006
High-resolution dissociative recombination of cold H3+and first evidence for nuclear spin effectsH Kreckel, M Motsch, J Mikosch, et al.
ESMO Open|April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoringB Gyawali, E G E de Vries, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2025
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)N I Cherny, S F Oosting, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2023
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0B Kiesewetter, U Dafni, E G E de Vries, et al.
British Journal of Haematology|November 3, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myelomaM R Seefat, D G J Cucchi, L van Boven, et al.
Pageof 11